PURCHASE AGREEMENT
among
REPUBLIC FIRST BANCORP,
INC.,
REPUBLIC FIRST BANCORP CAPITAL
TRUST IV
and
VERNON W. HILL,
II,
THE HARRY D. MADONNA FAMILY
TRUST,
STEVEN
M. LEWIS,
JOHN P. SILVESTRI,
and
THEODORE J. FLOCCO,
JR.,
AS
PURCHASERS
________________
Dated as of June 10, 2008
________________
PURCHASE AGREEMENT
$10,800,000 Convertible
Trust Preferred Securities
THIS PURCHASE AGREEMENT (the
“Agreement”), dated as of June 10, 2008 (the
“Closing Date”), is entered into among, Republic First
Bancorp, Inc., a Pennsylvania corporation (the
“Company”), Republic First Bancorp Capital Trust IV, a
statutory trust organized under the Delaware Statutory Trust Act
(the “Delaware Act”), 12 Del. C. § 3801 et
seq. (the “Trust,” and, together with the
Company, the “Offerors”), and the Purchasers as set
forth in Schedule A (each, a “Purchaser” and together,
the “Purchasers”).
WITNESSETH:
WHEREAS, the Offerors propose that the Trust
issue and sell an aggregate of 10,800 Convertible Capital
Securities of the Trust (with a stated liquidation amount of $1,000
per capital security) having the terms described in the Declaration
(defined below) (“Capital Securities”) to the
Purchasers;
WHEREAS the Capital Securities will be
convertible into common stock of the Company, par value $0.01 per
share (“Common Stock”), by the Purchasers (i) at any
time on or after the occurrence of the following events: (1) if, as
of the last day of any calendar quarter beginning with the quarter
June 30, 2008, the closing sale price of the Common Stock for at
least 20 trading days in a period of 30 consecutive trading days
ending on the last trading day of such calendar quarter is more
than 110% of the conversion price in effect on the last day of such
calendar; (2) upon the occurrence of the following corporate
events: (a) a “change in control” of the Company, which
will be deemed to have occurred at such time as a report is filed
on Schedule 13D or TO disclosing that any person has become the
beneficial owner of 50% or more of the voting power of the Common
Stock then outstanding, (b) any compulsory share exchange, (c) any
consolidation of the Company with, or merger of the Company into
any other person, any merger of another person into the Company
(other than a merger which does not result in a reclassification,
conversion, exchange or cancellation of outstanding shares of
Common Stock), or (d) any sale, transfer or lease of all or
substantially all of the assets of the Company; (ii) at any time
after June 30, 2009; and (iii) on the business day immediately
preceding the date of repayment of such Capital Securities, whether
at stated maturity or upon redemption;
WHEREAS the Company may redeem the Capital
Securities, subject to conditions set forth in the Indenture, prior
to maturity, in whole or in part, on one or more occasions (i) at
any time on or after June 30, 2013 if the Closing Price (as defined
in the Indenture, which is defined below) of Common Stock for 20
Trading Days (as defined in the Indenture) in a period of 30
consecutive Trading Days ending on the Trading Day prior to the
mailing of the notice of redemption exceeds 120% of the then
prevailing Conversion Price (as defined in the Indenture); and (ii)
at any time on or after June 30, 2018;
WHEREAS, the entire proceeds from the sale by
the Trust of the Capital Securities will be combined with the
entire proceeds from the sale by the Trust to the Company of 335
common securities (the “Common Securities”);
and
WHEREAS, the Capital Securities will be
guaranteed by the Company to the extent provided in the Guarantee
Agreement, dated as of the Closing Date (the “Guarantee
Agreement”), between the Company, as guarantor, and
Wilmington Trust Company, as guarantee trustee (the
“Guarantee Trustee”), with respect to distributions and
payments upon liquidation, redemption and otherwise; and
WHEREAS, the entire proceeds from the sale of
the Capital Securities will be combined with the entire proceeds
from the sale by the Trust to the Company of its common securities
(the “Common Securities”), and will be used by the
Trust to purchase $11,135,000 aggregate principal amount of
Convertible Junior Subordinated Debt Securities due 2038 (the
“Subordinated Debt Securities”) issued by the
Company. The Capital Securities and the Common
Securities will be issued pursuant to the Amended and Restated
Declaration of Trust, to be dated as of the Closing Date (the
“Declaration”), among the Company, as sponsor, the
Administrators named therein (the “Administrators”),
Wilmington Trust Company, as institutional trustee (the
“Institutional Trustee”), Wilmington Trust Company, as
Delaware trustee (the “Delaware Trustee”), and the
holders, from time to time, of undivided beneficial interests in
the assets of the Trust. The Subordinated Debt
Securities will be issued pursuant to the Indenture, to be dated as
of the Closing Date (the “Indenture”), between the
Company and Wilmington Trust Company, as indenture trustee (the
“Indenture Trustee”). The Indenture, the
Guarantee Agreement, the Declaration, and this Agreement are
hereinafter referred to collectively as the “Operative
Documents.”
NOW, THEREFORE, in consideration of the
foregoing and the mutual agreements and subject to the terms and
conditions herein set forth, the parties hereto agree as
follows:
SECTION 1. Representations
and Warranties of the Offerors .
(a) The Trust and the
Company, jointly and severally, represent and warrant to each
Purchaser of Capital Securities as of the date hereof and as of the
Closing Date, and agree with each Purchaser, as follows:
(i) Similar
Offerings . Within a period of six months before or
after the date hereof, the Offerors have not, directly or
indirectly, solicited any offer to buy or offered to sell, and will
not, directly or indirectly, solicit any offer to buy or offer to
sell, in the United States or to any United States citizen or
resident, any security which is or would be integrated with the
sale of the Capital Securities (including any securities of the
same or a similar class as the Capital Securities) in a manner that
would require the Capital Securities to be registered under the
Securities Act of 1933, as amended (the “1933
Act”).
(ii) Incorporated
Documents . The documents of the Company filed with
the Securities and Exchange Commission (the
“Commission”) in accordance with the Securities
Exchange Act of 1934, as amended (the “1934 Act”), from
and including the commencement of the fiscal year covered by the
Company’s most recent Annual Report on Form 10-K, at the time
they were or hereafter are filed by the Company with the Commission
(collectively, the “1934 Act Reports”), complied and
will comply in all material respects with the requirements of the
1934 Act and the rules and regulations of the Commission thereunder
(the
“1934 Act
Regulations”), and, at the date of this Agreement and on the
Closing Date, do not and will not include an untrue statement of a
material fact or omit to state a material fact required to be
stated therein or necessary to make the statements therein, in the
light of the circumstances under which they were made, not
misleading; and other than such instruments, agreements, contracts
and other documents as are filed as exhibits to the Company’s
Annual Report on Form 10-K, Quarterly Reports on Form 10-Q or
Current Reports on Form 8-K, there are no instruments, agreements,
contracts or documents of a character described in Item 601 of
Regulation S-K promulgated by the Commission to which the Company
or any of its subsidiaries is a party.
(iii) Independent
Accountants . The accountants of the Company who
certified the financial statements included in the 1934 Act Reports
(the “Independent Accountants”) are independent public
accountants of the Company and its subsidiaries within the meaning
of the 1933 Act and the rules and regulations of the Commission
thereunder (the “1933 Act Regulations”).
(iv) Financial
Statements and Information . The consolidated
historical financial statements of the Company, together with the
related schedules and notes, included in the 1934 Act Reports
present fairly, in all material respects, the respective
consolidated financial positions of the Company and its
consolidated subsidiaries at the respective dates indicated, and
the consolidated statements of income, changes in
stockholders’ equity and cash flows of the Company and its
consolidated subsidiaries for the respective periods specified;
said financial statements have been prepared in conformity with
generally accepted accounting principles in the United States
applied on a consistent basis throughout the periods involved,
except as disclosed in the notes to such financial statements; the
supporting schedules, if any, included in the 1934 Act Reports
present fairly, in all material respects, the information required
to be stated therein; and any pro forma financial statements and
the related notes thereto included in the 1934 Act Reports present
fairly, in all material respects, the information shown therein,
have been prepared in accordance with the Commission’s rules
and guidelines with respect to pro forma financial statements and
have been properly compiled on the bases described therein, and the
assumptions used in the preparation thereof are reasonable and the
adjustments used therein are appropriate to give effect to the
transactions and circumstances referred to therein.
(v) No Material
Adverse Change . Since March 31, 2008, there have
not been (A) any events, changes, or circumstances that have
occurred or are occurring that, singularly or in the aggregate, has
had or would reasonably be expected to result in a material adverse
change in the condition, financial, regulatory or otherwise, or in
the business affairs, management, stockholders’ equity,
results of operations, or business prospects of the Trust or of the
Company and its subsidiaries, each of which is listed in Schedule
B, considered as one enterprise, whether or not arising in the
ordinary course of business (a “Material Adverse
Effect”) or (B) any dividend or distribution of any kind
declared, paid or made by the Company on any class of its capital
stock other than regular quarterly dividends on the Company’s
common stock declared and paid consistent with past
practice.
(vi) Internal
Accounting Controls . The Company and its
subsidiaries maintain a system of internal accounting controls
sufficient to provide reasonable assurance that (i) transactions
are executed in accordance with the management’s general or
specific
authorizations,
(ii) transactions are recorded as necessary to permit preparation
of financial statements in conformity with generally accepted
accounting principles and to maintain asset accountability, (iii)
access to assets is permitted only in accordance with the
management’s general or specific authorization and (iv) the
recorded accountability for assets is compared with the existing
assets at reasonable intervals and appropriate action is taken with
respect to any differences.
(vii) Disclosure
Controls . The Company has established and maintains
disclosure controls and procedures (as such term is defined in Rule
13a-15(e) and 15d-15(e) under the 1934 Act); such disclosure
controls and procedures (i) are designed to ensure that material
information relating to the Company, including its consolidated
subsidiaries, is made known to the Company’s Chief Executive
Officer and its Chief Financial Officer by others within those
entities, particularly during the periods in which the 1934 Act
Reports are being prepared, (ii) have been evaluated for
effectiveness as of the end of the annual or quarterly period
reported to the Commission and (iii) are effective to perform the
functions for which they were established; the Company’s
auditors and the Audit Committee of the Board of Directors have
been advised of: (A) any significant deficiencies in the design or
operation of internal controls which could adversely affect the
Company’s ability to record, process, summarize, and report
financial data and (B) any fraud, whether or not material, that
involves management or other employees who have a role in the
Company’s internal controls; any material weaknesses in
internal controls have been identified for the Company’s
auditors; and since the date of the most recent evaluation of such
disclosure controls and procedures, there have been no significant
changes in internal controls or in other factors that could
significantly affect internal controls, including any corrective
actions with regard to significant deficiencies and material
weaknesses.
(viii) Regulatory
Matters . (a) Neither the Company nor any of its
subsidiaries is subject or is party to, or has received any written
notice that any of them may become subject or party to any
investigation with respect to, any corrective, suspension or
cease-and-desist order, agreement, consent agreement, memorandum of
understanding or other regulatory enforcement action, proceeding or
order with or by, or is a party to any commitment letter or similar
undertaking to, or is subject to any directive by, or has been a
recipient of any supervisory letter from, or has adopted any board
resolutions at the request of, any Regulatory Agency (as defined
below) that currently (i) restricts in any material respect the
conduct of their business, (ii) relates to their capital adequacy
or (iii) in any material manner relates to their management or
business (each, a “Regulatory Agreement”), nor has the
Company or any of its subsidiaries been advised in writing by any
Regulatory Agency that it is considering issuing or requesting any
such Regulatory Agreement; there is no unresolved violation,
criticism or exception by any Regulatory Agency with respect to any
report or statement relating to any examinations of the Company or
any of its subsidiaries which would reasonably be expected to have
a Material Adverse Effect. As used herein, the term
“Regulatory Agency” means any federal or state agency
charged with the supervision or regulation of depositary
institutions or holding companies of depositary institutions, or
engaged in the insurance of depositary institution deposits, or any
court, administrative agency or commission or other governmental
agency, authority or instrumentality having supervisory or
regulatory authority with respect to the Company or any of its
subsidiaries.
(b) Since January 1, 2005, the
Company and its Significant Subsidiary has timely filed all
reports, registration statements, proxy statements and other
materials, together with any amendments required to be made with
respect thereto, that were required to be filed with (i) the Office
of Thrift Supervision, (ii) the Office of the Comptroller of the
Currency, (iv) the Federal Reserve Board, (iii) the Federal Deposit
Insurance Corporation (the “FDIC”) and (iv) any other
federal, state or foreign Governmental Entity (all such reports and
statements are collectively referred to herein as the
“Reports”), and have paid all fees and assessments due
and payable in connection therewith. As of their respective dates,
the Reports complied in all material respects with all of the
statutes and published rules and regulations enforced or
promulgated by the regulatory authority with which they were filed
and with respect to all other Reports, were complete and accurate
in all material respects as of their respective
dates. There are no facts existing as of the date hereof
peculiar to the Company or its Significant Subsidiary that the
Company has not disclosed in the Reports or to the Purchasers in
writing that, individually or in the aggregate, have had or would
reasonably be expected to have a Material Adverse
Effect.
(ix) No Undisclosed
Liabilities . Neither the Company nor any of its
subsidiaries has any material liability, whether known or unknown,
whether asserted or unasserted, whether absolute or contingent,
whether accrued or unaccrued, whether liquidated or unliquidated,
and whether due or to become due, including any liability for taxes
(and there is no past or present fact, situation, circumstance,
condition or other basis for any present or future action, suit,
proceeding, hearing, charge, complaint, claim or demand against the
Company or its subsidiaries giving rise to any such liability),
except (i) for liabilities set forth in the financial statements
referred to in Section 1(a)(iv) above and (ii) normal fluctuations
in the amount of the liabilities referred to in clause (i) above
occurring in the ordinary course of business of the Company and all
of its subsidiaries since the date of the most recent balance sheet
included in such financial statements.
(x) Good Standing
of the Company . The Company has been duly organized
and is validly existing as a corporation in good standing under the
laws of the Commonwealth of Pennsylvania and has full power and
authority under such laws to own, lease and operate its properties
and to conduct its business, to enter into and perform its
obligations under each of the Operative Documents to which it is a
party, and to issue the Subordinated Debt Securities; and the
Company is duly registered as a bank holding company under the Bank
Holding Company Act of 1956, as amended.
(xi) Good Standing
of the Subsidiaries . The “significant
subsidiary” (as defined in Rule 1-02 of Regulation S-X) of
the Company (the “Significant Subsidiary”) has been
duly organized and is validly existing as an entity in good
standing under the laws of the jurisdiction in which it is
chartered and has full power and authority under such laws to own,
lease and operate its properties and to conduct its current and
contemplated business; and the deposit accounts of Republic First
Bank (the “Bank”) are insured up to the applicable
limits by the Deposit Insurance Fund of the FDIC to the fullest
extent permitted by law and the rules and regulations of the FDIC,
and no proceeding for the revocation or termination of such
insurance is pending or, to the knowledge of the Company,
threatened. The Company’s only Significant
Subsidiary is the Bank.
(xii) Foreign
Qualifications . Each of the Company and its
Significant Subsidiary is duly qualified as a foreign entity to
transact business, and each is in good standing in each
jurisdiction in which such qualification is required, whether by
reason of the ownership or leasing of property or the conduct of
business, except where the failure to be so qualified would not
reasonably be expected to have, singularly or in the aggregate, a
Material Adverse Effect.
(xiii) Capital Stock
Duly Authorized and Validly Issued . All of the
issued and outstanding capital stock of the Company has been duly
authorized and validly issued and is fully paid and nonassessable;
all of the issued and outstanding capital stock of the Significant
Subsidiary of the Company has been duly authorized and validly
issued, is fully paid and nonassessable and is owned by the
Company, directly or through subsidiaries, free and clear of any
security interest, mortgage, pledge, lien, encumbrance, claim or
equitable right; and none of the issued and outstanding capital
stock of the Company or its Significant Subsidiary was issued in
violation of any preemptive or similar rights arising by operation
of law, under the charter, by-laws or code of regulations of the
Company or its Significant Subsidiary or under any agreement to
which the Company or its Significant Subsidiary is a
party.
(xiv)
Capitalization . (a) The authorized capital stock
of the Company consists of (A) 20,000,000 shares of Common Stock,
of which as of the date of this Agreement, 10,811,747 shares were
issued and outstanding and (B) 10,000,000 shares of preferred
stock, of which as of the date of this Agreement, no shares were
issued and outstanding. As of March 31, 2008, the
Company held 416,303 shares of Common Stock in its
treasury. As of March 31, 2008, there were 663,044
shares of Common Stock reserved for issuance in connection with
employee benefit, stock option and dividend reinvestment and stock
purchase plans. All of the issued and outstanding shares of the
Company’s capital stock have been duly and validly authorized
and issued and are fully paid and nonassessable, and are not
subject to preemptive rights. No bonds, debentures,
notes or other indebtedness having the right to vote on any matters
on which the stockholders of the Company may vote (“Voting
Debt”) are issued and outstanding. Other than as
set forth herein or pursuant to this Agreement, (A) no equity
securities or Voting Debt of the Company are or may be required to
be issued by reason of any options, warrants, rights to subscribe
to, calls or commitments of any character whatsoever, (B) there are
outstanding no securities or rights convertible into or
exchangeable for any equity securities or Voting Debt of the
Company and (C) there are no contracts, commitments, understandings
or arrangements by which the Company is bound to issue additional
equity securities or Voting Debt or options, warrants or rights to
purchase or acquire any additional equity securities or Voting
Debt.
(b) Except for any director
qualifying shares, all of the issued and outstanding shares of
capital stock or other equity ownership interests of each
Subsidiary of the Company are owned by the Company, directly or
indirectly, free and clear of any material liens, pledges, charges
and security interests and similar encumbrances, and all of such
shares or equity ownership interests have been duly and validly
authorized and issued and are fully paid and nonassessable, and are
not subject to preemptive rights. No Subsidiary of the Company has
or is bound by any outstanding subscriptions, options, warrants,
calls, commitments or agreements of any character calling for the
purchase or issuance of any shares of capital stock or any
other
equity security
of such Subsidiary or any securities representing the right to
purchase or otherwise receive any shares of capital stock or any
other equity security of such Subsidiary.
(xv) Good Standing
of the Trust . The Trust has been duly created and
is validly existing in good standing as a statutory trust under the
Delaware Act with the power and authority to own property and to
conduct its business as provided in the Declaration, to enter into
and perform its obligations under the Operative Documents to which
it is a party, and to issue the Capital Securities and the Common
Securities; the Trust is not a party to or otherwise bound by any
agreement other than the Operative Documents to which it is a
party; and the Trust is, and will be, under current law, classified
for United States federal income tax purposes as a grantor trust
and not as an association taxable as a corporation.
(xvi) Authorization
of Common Securities . On the Closing Date, the
Common Securities will have been duly authorized for issuance by
the Trust pursuant to the Declaration and, when duly issued and
executed in accordance with the Declaration and delivered by the
Trust to the Company against payment therefor in accordance with
the subscription agreement therefor, will be validly issued and
fully paid and nonassessable undivided common beneficial ownership
interests in the assets of the Trust; the issuance of the Common
Securities is not subject to preemptive or other similar rights;
and on the Closing Date, all of the issued and outstanding Common
Securities of the Trust will be owned directly by the Company, free
and clear of any security interest, mortgage, pledge, lien,
encumbrance, claim or equitable right.
(xvii) Authorization
of Capital Securities . On the Closing Date, the
Capital Securities will have been duly authorized for issuance by
the Trust pursuant to the Declaration and, when duly issued,
executed and authenticated in accordance with the Declaration and
delivered by the Trust against payment therefor as provided herein
and will be validly issued and fully paid and nonassessable
undivided preferred beneficial ownership interests in the assets of
the Trust; the issuance of the Capital Securities will not be
subject to preemptive or other similar rights; and the Capital
Securities will be in the form contemplated by, and entitled to the
benefits of, the Declaration.
(xviii) Authorization
of Common Stock . On the Closing Date, the Common
Stock into which the Capital Securities or Debt Securities are
convertible pursuant to the Declaration and the Indenture will have
been duly authorized for issuance by the Company and, upon
conversion, all such stock will be validly issued and fully paid
and nonassessable and will have the same relative rights as, and
will be identical in all respects with, every other share of Common
Stock.
(xix) Authorization
of this Agreement . This Agreement has been duly
authorized, executed and delivered by each of the Offerors and
assuming due authorization, execution and delivery by the
Purchasers, will constitute a valid, legal and binding agreement of
each of the Offerors, enforceable against each of the Offerors in
accordance with its terms, except to the extent that enforceability
may be limited by (a) bankruptcy, insolvency, reorganization,
moratorium, fraudulent conveyance or other similar laws now or
hereafter in effect relating to creditors’ rights generally
and (b) general principles of equity (regardless of
whether
enforceability is considered in a proceeding at law or in equity)
(collectively, the “Enforceability
Exceptions”).
(xx) Authorization
of Declaration . The Declaration has been duly
authorized by the Company and, on the Closing Date, will have been
duly executed and delivered by the Company and the Administrators,
and assuming due authorization, execution and delivery of the
Declaration by the Institutional Trustee and the Delaware Trustee,
the Declaration will constitute a valid, legal and binding
agreement of the Company, enforceable against the Company in
accordance with its terms, except to the extent that enforceability
may be limited by the Enforceability Exceptions.
(xxi) Authorization
of Guarantee Agreement . The Guarantee Agreement has
been duly authorized by the Company and, on the Closing Date, will
have been duly executed and delivered by the Company, and assuming
due authorization, execution and delivery of the Guarantee
Agreement by the Guarantee Trustee, the Guarantee Agreement will
constitute a valid, legal and binding agreement of the Company,
enforceable against the Company in accordance with its terms,
except to the extent that enforceability may be limited by the
Enforceability Exceptions.
(xxii) Authorization
of Indenture . The Indenture has been duly
authorized by the Company and, on the Closing Date, will have been
duly executed and delivered by the Company, and assuming due
authorization, execution and delivery of the Indenture by the
Indenture Trustee, the Indenture will constitute a valid, legal and
binding agreement of the Company, enforceable against the Company
in accordance with its terms, except to the extent that
enforceability may be limited by the Enforceability
Exceptions.
(xxiii) Authorization
of Subordinated Debt Securities . The Subordinated
Debt Securities have been duly authorized by the Company; on the
Closing Date, the Subordinated Debt Securities will have been duly
executed by the Company and, when authenticated in the manner
provided for in the Indenture and delivered by the Company to the
Trust against payment therefor as contemplated in the subscription
agreement therefor, will constitute valid, legal and binding
obligations of the Company, enforceable against the Company in
accordance with their terms, except to the extent that
enforceability may be limited by the Enforceability Exceptions; the
Subordinated Debt Securities will be in the form contemplated by,
and entitled to the benefits of, the Indenture; the Subordinated
Debt Securities constitute indebtedness of the Company for United
States federal income tax purposes and the Company has no present
intention to exercise its option to defer payments of interest on
the Subordinated Debt Securities as provided in the
Indenture.
(xxiv) Authorization
of Administrators . Each of the Administrators of
the Trust is an officer or employee of the Company or one of its
subsidiaries and has been duly authorized by the Company to execute
and deliver the Declaration.
(xxv) Not an
Investment Company . Neither the Trust nor the
Company is, and immediately following consummation of the
transactions contemplated hereby and the application of the net
proceeds therefrom neither the Trust nor the Company will be, an
“investment company” or an entity
“controlled” by an “investment company”, in
each case
within the
meaning of Section 3(a) of the Investment Company Act of 1940, as
amended (the “1940 Act”), without regard to Section
3(c) of the 1940 Act.
(xxvi) Absence of
Defaults and Conflicts . The Trust is not in
violation of the trust certificate of the Trust filed with the
State of Delaware (the “Trust Certificate”) or the
Declaration, and neither the Company nor its Significant Subsidiary
is in violation of its charter, by-laws or code of regulations;
none of the Trust, the Company or any subsidiary of the Company is
in default in the performance or observance of any obligation,
agreement, covenant or condition contained in any contract,
indenture, mortgage, deed of trust, loan or credit agreement, note,
lease or other agreement or instrument to which it is a party or by
which it or any of them may be bound or to which any of its
properties or assets is subject (collectively, “Agreements
and Instruments”), except for such defaults under Agreements
and Instruments that would not reasonably be expected to have a
Material Adverse Effect; and the execution, delivery and
performance of the Operative Documents by the Trust or the Company,
as the case may be, the issuance, sale and delivery of the Capital
Securities and the Subordinated Debt Securities, the consummation
of the transactions contemplated by the Operative Documents, and
compliance by the Trust and the Company with the terms of the
Operative Documents to which they are a party have been duly
authorized by all necessary corporate action on the part of the
Company and, on the Closing Date, will have been duly authorized by
all necessary action on the part of the Trust and do not and will
not, whether with or without the giving of notice or passage of
time or both, violate, conflict with or constitute a breach of, or
default or Repayment Event (as defined below) under, or result in
the creation or imposition of any, security interest, mortgage,
pledge, lien, charge, encumbrance, claim or equitable right upon
any properties or assets of the Trust or the Company or its
Significant Subsidiary pursuant to any of the Agreements and
Instruments, nor will such action result in any violation of the
provisions of the charter, by-laws or code of regulations of the
Company or its Significant Subsidiary or the Declaration or the
Trust Certificate, or violation by the Company or any of its
Significant Subsidiaries or bank subsidiaries of any applicable
law, statute, rule, regulation, judgment, order, writ or decree of
any government, government authority, agency (including, without
limitation, each applicable Regulatory Agency) or instrumentality
or court, domestic or foreign, having jurisdiction over the Trust
or the Company or any of its Significant Subsidiaries or bank
subsidiaries or their respective properties or assets
(collectively, “Governmental Entities”). As
used herein, a “Repayment Event” means any event or
condition which gives the holder of any note, debenture or other
evidence of indebtedness (or any person acting on such
holder’s behalf) the right to require the repurchase,
redemption or repayment of all or a portion of such indebtedness by
the Trust or the Company or its Significant Subsidiary prior to its
scheduled maturity.
(xxvii) ERISA
. (a) All “employee benefit plans”, as
defined in Section 3(3) of the Employee Retirement Income Security
Act of 1974, as amended (“ERISA”), that are subject to
Title I of ERISA and are currently maintained or maintained since
January 1, 2003, by either the Company or any companies which, with
the Company, would be deemed to be a single employer under Section
414(b), (c), (m) or (o) of the Code (collectively, the
“Company Group”) for the benefit of the Company Group
employees, are collectively, for purposes of this Agreement,
referred to herein as the “Company
Plans.” All Company Plans that constitute employee
“pension plans” as defined in Section 3(2) of ERISA
that are subject to Title IV of ERISA are referred to herein as the
“Company Pension Plans.” Except as would not
reasonably be expected to have, singularly or in the aggregate, a
Material Adverse Effect, to the knowledge
of the Company,
no non-exempt “prohibited transaction” (as such term is
used in Section 406 of ERISA or Section 4975 of the Code), has
heretofore occurred with respect to any Company Plan or any Company
Pension Plan and, to the knowledge of the Company, no such
non-exempt prohibited transaction with respect to any Company Plan
or Company Pension Plan shall occur as a result of the execution
and delivery of this Agreement and the consummation of the
transactions contemplated herein.
(b) Except as would not reasonably be
expected to have, singularly or in the aggregate, a Material
Adverse Effect, the consummation of the transactions contemplated
hereby will not result in an increase in the amount of, or
acceleration in the timing of payment of vesting of, any
compensation payable or awarded by the Company or its Significant
Subsidiary to any of its or their employees under any employment
agreements, plans or programs of the Company or its Significant
Subsidiary.
(xxviii) Intellectual
Property . (a) the Company and its Significant
Subsidiary owns, or is licensed to use (in each case, free and
clear of any claims, liens or encumbrances), all Intellectual
Property (as defined below) used in or necessary for the conduct of
its business as currently conducted; (b) the use of any
Intellectual Property by the Company and its Significant Subsidiary
does not, to the knowledge of the Company, infringe on or otherwise
violate the rights of any person and is in accordance with any
applicable license pursuant to which the Company or its Significant
Subsidiary acquired the right to use any Intellectual Property; (c)
no person is challenging, infringing on or otherwise violating any
right of the Company or any of its Significant Subsidiary with
respect to any material Intellectual Property owned by or licensed
to the Company or its Significant Subsidiary; (d) to the knowledge
of the Company, neither the Company nor its Significant Subsidiary
has received any notice of any pending claim with respect to any
Intellectual Property used by the Company or its Significant
Subsidiary; and (e) to the knowledge of the Company, no
Intellectual Property owned or licensed by the Company or its
Significant Subsidiary is being used or enforced in a manner that
would be expected to result in the abandonment, cancellation or
unenforceability of such Intellectual Property. In this
Section 1(xxviii), “Intellectual Property” shall mean
trademarks, service marks, brand names, certification marks, trade
dress and other indications of origin, the goodwill associated with
the foregoing and registrations in any jurisdiction of, and
applications in any jurisdiction to register, the foregoing,
including any extension, modification or renewal of any such
registration or application; inventions, discoveries and ideas,
whether patentable or not, in any jurisdiction; patents,
applications for patents (including divisions, continuations,
continuations in part and renewal applications), and any renewals,
extensions or reissues thereof, in any jurisdiction; nonpublic
information, trade secrets and confidential information and rights
in any jurisdiction to limit the use or disclosure thereof by any
person; writings and other works, whether copyrightable or not, in
any jurisdiction; and registrations or applications for
registration of copyrights in any jurisdiction, and any renewals or
extensions thereof; and any similar intellectual property or
proprietary rights.
|